{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T22:16:23Z","timestamp":1794608183912,"version":"4.9.1"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Intestinal ischemia\/reperfusion (I\/R) challenge often results in gut barrier dysfunction and induces distant organ injury. Dexmedetomidine has been shown to protect intestinal epithelial barrier against I\/R attack. The present study aims to investigate the degree to which intestinal I\/R attack will contribute to gut-vascular barrier (GVB) damage, and to examine the ability of dexmedetomidine to minimize GVB and liver injuries in mice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>\n                      In vivo, intestinal ischemic challenge was induced in mice by clamping the superior mesenteric artery for 45 minutes. After clamping, the mice were subjected to reperfusion for either 2, 4, 6, or 12 hours. Intraperitoneal injection of dexmedetomidine 15, 20, or 25 \u03bcg\u00b7kg\n                      <jats:sup>\u20131<\/jats:sup>\n                      was performed intermittently at the phase of reperfusion. For the in vitro experiments, the challenge of oxygen-glucose deprivation\/reoxygenation (OGD\/R) was established in cultured vascular endothelial cells, and dexmedetomidine (1 nM) was used to treat the cells for 24 hours. Moreover, in vivo and in vitro, SKL2001 (a specific agonist of \u03b2-catenin) or XAV939 (a specific inhibitor of \u03b2-catenin) was applied to determine the role of \u03b2-catenin in the impacts provided by dexmedetomidine.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      The attack of intestinal I\/R induced GVB damage. The greatest level of damage was observed at 4 hours after intestinal reperfusion. There was a significant increase in plasmalemma vesicle\u2013associated protein-1 (PV1, a specific biomarker for endothelial permeability) expression (5.477 \u00b1 0.718 vs 1.000 \u00b1 0.149;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001), and increased translocation of intestinal macromolecules and bacteria to blood and liver tissues was detected (all\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001). Liver damages were observed. There were significant increases in histopathological scores, serum parameters, and inflammatory factors (all\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001). Dexmedetomidine 20 \u03bcg\u00b7kg\n                      <jats:sup>\u20131<\/jats:sup>\n                      reduced PV1 expression (0.466 \u00b1 0.072 vs 1.000 \u00b1 0.098;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001) and subsequent liver damages (all\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .01). In vitro, dexmedetomidine significantly improved vascular endothelial cell survival (79.387 \u00b1 6.447% vs 50.535 \u00b1 1.766%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001) and increased the productions of tight junction protein and adherent junction protein (all\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .01) following OGD\/R. Importantly, in cultured cells and in mice, \u03b2-catenin expression significantly decreased (both\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001) following challenge. Dexmedetomidine or SKL2001 upregulated \u03b2-catenin expression and produced protective effects (all\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .01). However, XAV939 completely eliminated the protective effects of dexmedetomidine on GVB (all\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>The disruption of GVB occurred following intestinal I\/R. Dexmedetomidine alleviated I\/R-induced GVB impairment and subsequent liver damage.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000005810","type":"journal-article","created":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T13:09:44Z","timestamp":1639141784000},"page":"419-431","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":33,"title":["Dexmedetomidine Alleviates Gut-Vascular Barrier Damage and Distant Hepatic Injury Following Intestinal Ischemia\/Reperfusion Injury in Mice"],"prefix":"10.1213","volume":"134","author":[{"given":"Yi-Nan","family":"Zhang","sequence":"first","affiliation":[{"name":"Departments of Anesthesiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze-Nan","family":"Chang","sequence":"additional","affiliation":[{"name":"Critical Care Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Meng","family":"Liu","sequence":"additional","affiliation":[{"name":"Critical Care Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Hong","family":"Wen","sequence":"additional","affiliation":[{"name":"Departments of Anesthesiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Qing","family":"Zhan","sequence":"additional","affiliation":[{"name":"Departments of Anesthesiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Jin","family":"Lai","sequence":"additional","affiliation":[{"name":"Critical Care Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu-Fei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Departments of Anesthesiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Guo","sequence":"additional","affiliation":[{"name":"Departments of Anesthesiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-Yu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Departments of Anesthesiology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,12,10]]},"reference":[{"key":"R1-20250502","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1023\/B:DDAS.0000042232.98927.91","article-title":"Ischemia-reperfusion injury of the intestine and protective strategies against injury.","volume":"49","author":"Mallick","year":"2004","journal-title":"Dig Dis Sci"},{"key":"R2-20250502","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1097\/00000542-200106000-00030","article-title":"Pathophysiology, clinical manifestations, and prevention of ischemia-reperfusion injury.","volume":"94","author":"Collard","year":"2001","journal-title":"Anesthesiology"},{"key":"R3-20250502","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/jcmm.12987","article-title":"Necroptosis is a key mediator of enterocytes loss in intestinal ischaemia\/reperfusion injury.","volume":"21","author":"Wen","year":"2017","journal-title":"J Cell Mol Med"},{"key":"R4-20250502","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.surg.2012.09.017","article-title":"Ischemic postconditioning during reperfusion attenuates oxidative stress and intestinal mucosal apoptosis induced by intestinal ischemia\/reperfusion via aldose reductase.","volume":"153","author":"Wen","year":"2013","journal-title":"Surgery"},{"key":"R5-20250502","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1126\/science.aad0135","article-title":"A gut-vascular barrier controls the systemic dissemination of bacteria.","volume":"350","author":"Spadoni","year":"2015","journal-title":"Science"},{"key":"R6-20250502","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.ccell.2021.03.004","article-title":"Gut vascular barrier impairment leads to intestinal bacteria dissemination and colorectal cancer metastasis to liver.","volume":"39","author":"Bertocchi","year":"2021","journal-title":"Cancer Cell"},{"key":"R7-20250502","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1056\/NEJMoa1904710","article-title":"Early sedation with dexmedetomidine in critically ill patients.","volume":"380","author":"Shehabi","year":"2019","journal-title":"N Engl J Med"},{"key":"R8-20250502","doi-asserted-by":"crossref","first-page":"7857082","DOI":"10.1155\/2019\/7857082","article-title":"Irisin contributes to the hepatoprotection of dexmedetomidine during intestinal ischemia\/reperfusion.","volume":"2019","author":"Fan","year":"2019","journal-title":"Oxid Med Cell Longev"},{"key":"R9-20250502","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12967-018-1455-1","article-title":"Dexmedetomidine attenuates lung apoptosis induced by renal ischemia-reperfusion injury through \u03b12AR\/PI3K\/Akt pathway.","volume":"16","author":"Li","year":"2018","journal-title":"J Transl Med"},{"key":"R10-20250502","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1007\/s10753-019-01082-2","article-title":"Role of JNK signaling pathway in dexmedetomidine post-conditioning-induced reduction of the inflammatory response and autophagy effect of focal cerebral ischemia reperfusion injury in rats.","volume":"42","author":"Zhu","year":"2019","journal-title":"Inflammation"},{"key":"R11-20250502","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.biopha.2017.06.050","article-title":"Dexmedetomidine preconditioning protects against retinal ischemia\/reperfusion injury and inhibits inflammation response via toll-like receptor 4 (TLR4) pathway.","volume":"93","author":"Chen","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"R12-20250502","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1097\/ALN.0b013e3182503964","article-title":"Dexmedetomidine administration before, but not after, ischemia attenuates intestinal injury induced by intestinal ischemia-reperfusion in rats.","volume":"116","author":"Zhang","year":"2012","journal-title":"Anesthesiology"},{"key":"R13-20250502","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/ALN.0000000000001135","article-title":"Effects of dexmedetomidine on intestinal microcirculation and intestinal epithelial barrier in endotoxemic rats.","volume":"125","author":"Yeh","year":"2016","journal-title":"Anesthesiology"},{"key":"R14-20250502","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.bbi.2020.10.008","article-title":"Dexmedetomidine attenuates sepsis-associated inflammation and encephalopathy via central \u03b12A adrenoceptor.","volume":"91","author":"Mei","year":"2021","journal-title":"Brain Behav Immun"},{"key":"R15-20250502","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1126\/science.aad6768","article-title":"Immunology. Breaching the gut-vascular barrier.","volume":"350","author":"Bouziat","year":"2015","journal-title":"Science"},{"key":"R16-20250502","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3389\/fbioe.2020.00647","article-title":"Laminar flow protects vascular endothelial tight junctions and barrier function via maintaining the expression of long non-coding RNA MALAT1.","volume":"8","author":"Yang","year":"2020","journal-title":"Front Bioeng Biotechnol"},{"key":"R17-20250502","doi-asserted-by":"crossref","first-page":"2930463","DOI":"10.1155\/2020\/2930463","article-title":"Dexmedetomidine attenuates LPS-induced monocyte-endothelial adherence via inhibiting Cx43\/PKC-\u03b1\/NOX2\/ROS signaling pathway in monocytes.","volume":"2020","author":"Chai","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"R18-20250502","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cardiores.2003.10.014","article-title":"Norepinephrine induces apoptosis in neonatal rat endothelial cells via down-regulation of Bcl-2 and activation of beta-adrenergic and caspase-2 pathways.","volume":"61","author":"Fu","year":"2004","journal-title":"Cardiovasc Res"},{"key":"R19-20250502","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1001\/archsurg.1970.01340280030009","article-title":"Intestinal mucosal lesion in low-flow states .1. A morphological, hemodynamic, and metabolic reappraisal.","volume":"101","author":"Chiu","year":"1970","journal-title":"Archives of Surgery"},{"key":"R20-20250502","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1067\/msy.2002.125718","article-title":"17-Beta-estradiol protects the liver against warm ischemia\/reperfusion injury and is associated with increased serum nitric oxide and decreased tumor necrosis factor-alpha.","volume":"132","author":"Eckhoff","year":"2002","journal-title":"Surgery"},{"key":"R21-20250502","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1096\/fj.201900817R","article-title":"HMGB1-associated necroptosis and Kupffer cells M1 polarization underlies remote liver injury induced by intestinal ischemia\/reperfusion in rats.","volume":"34","author":"Wen","year":"2020","journal-title":"FASEB J"},{"key":"R22-20250502","doi-asserted-by":"crossref","first-page":"118460","DOI":"10.1016\/j.lfs.2020.118460","article-title":"Berberine reduces gut-vascular barrier permeability via modulation of ApoM\/S1P pathway in a model of polymicrobial sepsis.","volume":"261","author":"Li","year":"2020","journal-title":"Life Sci"},{"key":"R23-20250502","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited.","volume":"22","author":"Reagan-Shaw","year":"2008","journal-title":"FASEB J"},{"key":"R24-20250502","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1001\/jama.298.22.2644","article-title":"Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial.","volume":"298","author":"Pandharipande","year":"2007","journal-title":"JAMA"},{"key":"R25-20250502","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: pathophysiological basis for therapy.","volume":"72","author":"Albillos","year":"2020","journal-title":"J Hepatol"},{"key":"R26-20250502","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/hep.28456","article-title":"Interleukin-1 and inflammasomes in alcoholic liver disease\/acute alcoholic hepatitis and nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis.","volume":"64","author":"Tilg","year":"2016","journal-title":"Hepatology"},{"key":"R27-20250502","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nri.2017.100","article-title":"Organ-specific protection mediated by cooperation between vascular and epithelial barriers.","volume":"17","author":"Spadoni","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"R28-20250502","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/bja\/86.5.650","article-title":"Effects of dexmedetomidine on adrenocortical function, and the cardiovascular, endocrine and inflammatory responses in post-operative patients needing sedation in the intensive care unit.","volume":"86","author":"Venn","year":"2001","journal-title":"Br J Anaesth"},{"key":"R29-20250502","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S0002-9343(03)00165-7","article-title":"Alpha-2 adrenergic agonists to prevent perioperative cardiovascular complications: a meta-analysis.","volume":"114","author":"Wijeysundera","year":"2003","journal-title":"Am J Med"},{"key":"R30-20250502","doi-asserted-by":"crossref","first-page":"6120194","DOI":"10.1155\/2020\/6120194","article-title":"Dexmedetomidine ameliorates lung injury induced by intestinal ischemia\/reperfusion by upregulating cannabinoid receptor 2, followed by the activation of the phosphatidylinositol 3-Kinase\/Akt pathway.","volume":"2020","author":"Chen","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"R31-20250502","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.devcel.2014.11.016","article-title":"The endothelial transcription factor ERG promotes vascular stability and growth through Wnt\/\u03b2-catenin signaling.","volume":"32","author":"Birdsey","year":"2015","journal-title":"Dev Cell"},{"key":"R32-20250502","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.jhep.2019.08.005","article-title":"Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development.","volume":"71","author":"Mouries","year":"2019","journal-title":"J Hepatol"},{"key":"R33-20250502","doi-asserted-by":"crossref","first-page":"110001","DOI":"10.1016\/j.biopha.2020.110001","article-title":"Dexmedetomidine protects H9C2 against hypoxia\/reoxygenation injury through miR-208b-3p\/Med13\/Wnt signaling pathway axis.","volume":"125","author":"Wang","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"R34-20250502","doi-asserted-by":"crossref","first-page":"9043628","DOI":"10.1155\/2018\/9043628","article-title":"Dexmedetomidine reduces diabetic neuropathy pain in rats through the Wnt 10a\/\u03b2-catenin signaling pathway.","volume":"2018","author":"Zhong","year":"2018","journal-title":"Biomed Res Int"},{"key":"R35-20250502","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1080\/15384101.2021.1897270","article-title":"Dexmedetomidine upregulates microRNA-185 to suppress ovarian cancer growth via inhibiting the SOX9\/Wnt\/\u03b2-catenin signaling pathway.","volume":"20","author":"Tian","year":"2021","journal-title":"Cell Cycle"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000005810","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:34:34Z","timestamp":1786113274000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000005810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,10]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000005810","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,10]]}}}